ReviewPharmaceuticals (Basel, Switzerland)2026

Geranylgeraniol as a Modulator of Mevalonate Pathway Disruption: A Scoping Review of Cellular Mechanisms and Skeletal Outcomes in Osteoporosis Models.

Sophia Ogechi Ekeuku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.